the atopic derm and kyrzi brands are the most important markets for biologics and immunomodulators. they are the leading agents in the immunology space and they are now being used in psoriasis and rheumatology. the atopic derm and kryrzi are the most immature areas of the market. the atopic derm and the kyrzi are the most immature markets. the atopic derm and its atopic derm markets are still a $3.5 billion market with significant potential to grow. the atopic derm and our atopic derm markets are still, but there is still a large gap in the demand for biologics and the atopic dermatitis market is still a $3.5 billion market with significant opportunity to grow.